logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CNBM (03323): Liu Yan resigns as executive director

date
21:53 16/01/2025
avatar
GMT Eight
China Building Materials (03323) announced that on January 16, 2025, the company received the resignation letter from Mr. Liu Yan. Mr. Liu...
CNBM (03323) announced that on January 16, 2025, the company received Mr. Liu Yan's resignation letter. Mr. Liu has resigned as an executive director of the company due to job adjustment. The company also received Mr. Xiao Jiaxiang's resignation letter on January 16, 2025. Mr. Xiao has resigned as a non-executive director of the company due to retirement.
Related Articles
HK Stock Market Move | CLOUDBREAK-B(02592) dropped nearly 15% once. CBT-199, an ophthalmology candidate drug, has submitted a new drug clinical trial application in the United States.
New Stock News | Shenzhen Woer Heat-shrinkable Material (002130.SZ) Hong Kong IPO prospectus invalidated
Dual engines of government and enterprise drive rapid growth! The bullish logic of the "AI application myth" Palantir (PLTR.US) remains strong.
HK Stock Market Move | CLOUDBREAK-B(02592) dropped nearly 15% once. CBT-199, an ophthalmology candidate drug, has submitted a new drug clinical trial application in the United States.
New Stock News | Shenzhen Woer Heat-shrinkable Material (002130.SZ) Hong Kong IPO prospectus invalidated
Dual engines of government and enterprise drive rapid growth! The bullish logic of the "AI application myth" Palantir (PLTR.US) remains strong.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
icon
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
icon
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
icon
12/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.